Skip to content

Antraco, Inc.

United StatesFDA applicant, unverified

Devices
2

What Antraco, Inc. makes

Antraco, Inc. manufactures DIABRITE, a diagnostic device for blood glucose monitoring, and DIAGLAZE, a reagent-based system for glucose testing in clinical settings. These products are designed for point-of-care and laboratory use to measure glucose levels in blood samples.

The company’s portfolio is regulated under Class I medical devices in the U.S., with devices listed via the FDA’s 510(k) pathway. Both products are intended for compliance with U.S. regulatory requirements and are based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • Diabrite Ref K822894

    Active Regimes: 510(k) Registry: 510(k) Class:I

  • Diaglaze Ref K822142

    Active Regimes: 510(k) Registry: 510(k) Class:I

Frequently asked questions

How many devices does Antraco, Inc. have in the registry?

The registry currently lists 2 devices for Antraco, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Antraco, Inc.'s devices?

Among its 2 most recently registered devices, Antraco, Inc. has devices listed in FDA 510(k) (2 devices).

What risk classes do Antraco, Inc.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Antraco, Inc.'s devices are Class I. Each device page shows its own class and authorisation.

What are the newest devices from Antraco, Inc. in the registry?

The most recently registered devices listed for Antraco, Inc. include DIABRITE and DIAGLAZE.

Generated automatically from registry data and not verified by a human reviewer.